Harnessing Ultrasonic Technologies to Treat Staphylococcus Aureus Skin Infections

Area of Science:

• Biomedical Engineering
• Dermatology
• Infectious Diseases

Background:

• Antibiotic-resistant *Staphylococcus aureus*, including MRSA, pose significant challenges in treating skin and soft tissue infections (SSSIs).
• Biofilm formation and chronic wound development are common complications of *S. aureus* infections, necessitating novel therapeutic strategies.

Purpose of the Study:

• To review ultrasonic methodologies as adjunctive therapies for *S. aureus*-driven skin infections.
• To explore the potential of ultrasound in preventing biofilm formation and promoting tissue repair.
• To highlight localized delivery technologies for effective intervention in SSSIs.

Main Methods:

• Review of low-frequency ultrasound (LFU) and high-frequency ultrasound (HFU) applications.
• Integration of ultrasound with microbubbles and therapeutics (antibiotics, affimers).
• Investigation of localized delivery systems like microneedle patches and piezoelectric devices.

Main Results:

• Ultrasound demonstrates potential in disrupting bacterial biofilms through cavitation and microbubble activity.
• Ultrasonic approaches can enhance the delivery of antimicrobial agents and promote tissue regeneration.
• Tailored ultrasound bioeffects via localized delivery show promise for early SSSI intervention.

Conclusions:

• Ultrasonic methodologies represent a promising adjunctive approach to combatting antibiotic-resistant *S. aureus* infections.
• Combining ultrasound with targeted therapeutics and delivery systems can overcome resistance and improve treatment outcomes.
• Further research into localized ultrasound delivery systems is warranted for effective SSSI management.